Literature DB >> 765738

Control of gene expression in bacteriophage lambda: suppression of N mutants by mutations of the antirepressor.

P Galland, R Cortini, E Calef.   

Abstract

The lysogenization and induction properties of phages lambdasusN7CI857Ai7 and lambdasusN53cro27 are described. Both phages, at 32 degrees kill little, but show only a moderate frequency of lysogenization whether an amber suppressor is present or absent in the host bacterium. In the latter case, lysogens for lambdasusN7CI857Ai7 or lambdasusN53CI857cro27 can exist in two different regulatory states, here called P r- and Pr+. The Pr+ phase is characterized by phage release and cell death at 40 degrees; conversely, cells in the Pr- phase are similarly killed but release no or very little phage. Pr- is the phase usually obtained at lysogenization. Each phase may be transmitted at 32 degrees for an unlimited number of generations, however, shifts to the opposite phase take place from time to time with a low probability. Two previously described antirepressor defective mutants. Ai7 and cro27, were found to suppress specifically the growth defect caused by an amber mutation in gene N. This suppression is observed in non-suppressing hosts at 40 or 42 degrees. Apparent revertants of N- mutants were shown to be often (80%) caused by a second mutation, in the Ai gene (also called tof, cro and fed). All the revertants so far examined appeared to be recessive. Lambda phages bearing a double amber mutation in gene N did not acquire full N independence by the acquisiton of an Ai mutation; this could be achieved, however, in the presence of a CII mutation. The above findings are discussed in terms of a direct interaction between the N, Ai and CII products.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 765738     DOI: 10.1007/bf00266096

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  35 in total

1.  ON THE CONTROL OF THE REPLICATION OF TEMPERATE BACTERIOPHAGES SUPERINFECTING IMMUNE HOSTS.

Authors:  R THOMAS; L E BERTANI
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  [Not Available].

Authors:  F JACOB; E L WOLLMAN
Journal:  Ann Inst Pasteur (Paris)       Date:  1954-12

3.  [On a thermosensitive repression system in the Escherichia coli lambda bacteriophage].

Authors:  R SUSSMAN; F JACOB
Journal:  C R Hebd Seances Acad Sci       Date:  1962-02-19

4.  On the mode of antirepressor action in anti-immune cells.

Authors:  P Galland; P Bassi; E Calef
Journal:  Mol Gen Genet       Date:  1973-09-12

5.  Termination factor for RNA synthesis.

Authors:  J W Roberts
Journal:  Nature       Date:  1969-12-20       Impact factor: 49.962

6.  Two repressors in bacteriophage lambda.

Authors:  M Hampacherová; E Koutecká; Z Neubauer
Journal:  Mol Gen Genet       Date:  1973-01-24

7.  Studies of novel transducing variants of lambda: dispensability of genes N and Q.

Authors:  D Court; K Sato
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

8.  Studies on the genetics of biotin-transducing, defective variants of bacteriophage lambda.

Authors:  G Kayajanian
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

9.  Bidirectional transcription and the regulation of Phage lambda repressor synthesis.

Authors:  W G Spiegelman; L F Reichardt; M Yaniv; S F Heinemann; A D Kaiser; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

10.  Release of polarity in Escherichia coli by gene N of phage lambda: termination and antitermination of transcription.

Authors:  S Adhya; M Gottesman; B De Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

View more
  2 in total

1.  Isolation of suppressor sensitive mutants in the Ai gene of phage lambda.

Authors:  G Cesareni; S Nasi
Journal:  Mol Gen Genet       Date:  1976-12-08

2.  Normal expression of the viral gene N interferes with growth of bacteriophage lambda in Escherichia coli 15T-.

Authors:  N Gschwind; W Arber
Journal:  Mol Gen Genet       Date:  1977-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.